Investors are unsatisfied with the level of communication they receive from fund management on stewardship in relation to health, ShareAction research has found.
Sector remains a critical issue globally
Plans for eight sectors scrapped
Barclays Smart Investor research
UK unable to throw money at the situation
Fund will invest in a range of 35-40 companies
New drug launches need private finance
Most Q1 IPOs since 2007
The accelerated approval of the first new Alzheimer's treatment in almost two decades looks set to drive a new wave of biotech innovation and investment.
Covering two key megatrends